Expression of early growth response genes in human prostate cancer

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2461-2468

  Eid, Manal A ^a   Kumar, M Vijay ^a,b   Iczkowski, Kenneth A ^a   Bostwick, David G ^a   Tindall, Donald J ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; DIGOXIGENIN; MESSENGER RNA; RNA; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032100588     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sadasivan, R., Morgan, R., Jennings, S., Austenfeld, M., Veldhuizen, P. V., Stephens, R., and Noble, M. Overexpression of HER-2/Neu may be an indicator of poor prognosis in prostate cancer. J. Urol., 150: 126-131, 1993.
2. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Caplen, D. E., Yuan, J. J., Petros, J. A., and Andriole, G. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324: 1156-1161, 1991.
3. Stamey, A. T., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., and Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317: 909-916, 1987.
4. Littrup, P. J. Prostate cancer screening: appropriate choice? Cancer (Phila.), 74: 2016-2022, 1994.
5. Gashler, A., and Sukhatme, V. P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Progr. Nucleic Acid Res. Mol. Biol., 50: 191-224, 1995.
6. Chavrier, P., Zerial, M., Lemaire, P., Almemdral, J., Bravo, R., and Charnay, P. A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J., 7: 29-35, 1988.
7. Patwardhan, S., Gashler, A., Siegel, M. G., Chang, L. C., Joseph, L. J., Shows, T. B., Le Beau, M. M., and Sukhatme, V. P. EGR-3 a novel member of the egr family of genes encoding immediate-early transcription factors. Oncogene, 6: 917-928, 1991.
8. Crosby, S. D., Puetz, J. J., Simburger, K. S., Fahrner, T. J., and Milbrandt, J. The early response gene NGF1-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Mol. Cell. Biol., 11: 3835-3841, 1991.
9. Blok, L. J., Grossmann, M. E., Perry, J. E., and Tindall, D. J. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol. Endocrinol. 9: 1610-1620, 1995.
10. Joseph, L. J., Le Beau, M. M., Jamieson, G. A., Acharya, S., Shows, T. B., Rowley, J. D., and Sukhatme, V. P. Molecular cloning, sequencing, and mapping of EGR-2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc. Natl. Acad. Sci. USA, 85: 7164-7168, 1988.
11. Mages, H. W., Stamminger, T., Rilke, O., Bravo, R., and Kroczek, R. A. Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells. Int. Immunol., 5: 63-70, 1993.
12. Christy, B., and Nathans, D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA, 86: 8737-8741, 1989.
13. Paveletich, N. P., and Pabo, C. O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science (Washington DC), 252: 809-817, 1991.
14. Lemaire, P., Vesque, C., Schmitt, J., Stunnenberg, H., Frank, R., and Carnay, P. The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol. Cell. Biol., 10: 3456-3467, 1990.
15. Jamieson, G. A., Mayforth, R. D., Villreal, M. L., and Sukhatme, V. P. Multible intracellular pathways induce expression of a zinc-finger encoding gene (EGR-1): relationship to activation of the Na/H exchanger. J. Cell. Physiol., 139: 262-268, 1989.
16. Milbrandt, J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science (Washington DC), 238: 797-799, 1987.
17. Molnar, G., Crozat, A., and Pardee, A. B. The immediate early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol. Cell. Biol, 14: 5242-5248, 1994.
18. Thigpen, A. E., Cala, K. M., Guileyardo, J. M., Molberg, K. H., McConnell, J. D., and Russell, D. W. Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J. Urol., 155: 975-981, 1996.
19. Levin, W. J., Baynor, R. B., Press, M. F., Sukhatme, V. P., and Slamon, D. J. Differential expression of immediate early transcription factors in human lung. J. Cell. Biochem., 16: 240, 1992.
20. Huang, R., Liu, C., Fan, Y., Mercola, D., and Adamson, E. D. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res., 55: 5054-5062, 1995.
21. Suggs, S. V., Katzowitz, J. L., Tsai-Morris, C., and Sukhatme, V. P. cDNA sequence of the human cellular early growth response gene Egr-1. Nucleic Acids Res., 18: 4283, 1990.
22. Li, X., and Okita, T. W. Localization of RNA by high resolution in situ hybridization. Methods Cell Biol., 49: 185-199, 1995.
23. Gandrillon, O., Solari, F., Legrand, C., Jurdic, P., and Samarut, J. A rapid and convenient method to prepare DIG-labeled RNA probes for use in non-radioactive in situ hybridization. Mol. Cell. Probes, 10: 51-55, 1996.
24. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
25. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 15: 532-534, 1993.
26. McGarvey, T., Hussain, M. M., and Stearns, M. E. In situ hybridization studies of α2-macroglobulin receptor and receptor-associated protein in human prostate carcinoma. Prostate, 28: 311-317, 1996.
27. Wright, P. S., Cross-Doersen, D. E., Chmielewski, P. A., Bush, T. L., Bitonti, A. J., and Miller, J. A. Measurement of mRNA levels in tumor xenografts with quantitative autoradiography and in situ hybridization. FASEB J., 9: 279-283, 1995.
28. Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab., 81: 411-420, 1996.
29. Robb, R. A., and Hanson, D. P. A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas. Phys. Eng. Sci. Med., 14: 9-30, 1991.
30. Aihara, M., Libovitz, R. M., Wheeler, T. M., Kinner, B. M., Ohori, M., and Scardino, P. T. Prostate specific antigen and Gleason grade: an immunocytochemical study of prostate cancer. J. Urol., 151: 1558-1564, 1994.
31. Taylor, C. R., Shi, S., Chaiwun, B., Young, L., Iman, S.A., and Cote, R. J. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum. Pathol., 25: 263-270, 1994.
32. Sherka, C., Decker, E. L., and Zipfel, P. F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem., 270: 22500-22506, 1995.
33. Mohn, K. L., Laz, T. M., Hsu, J., Melby, A. E., Bravo, R., and Taub, R. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol. Cell. Biol., 11: 381-390, 1991.
34. Calogero, A., Cuomo, L., D'Onofrio, M., Grazia, U., Spinsanti, P., Mercola, D., Faggioni, A., Frati, L., Adamson, E. D., and Ragona, G. Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines. Oncogene, 13: 2105-2112, 1996.
35. Takimoto, Y., Wang, Z. Y., Kobler, K., and Deuel, T. F. Promoter region of the human platelet-derived growth factor A-chain gene. Proc. Natl, Acad. Sci. USA, 88: 1686-1690, 1991.
36. Gashler, A. L., Swaminathan, S., and Sukhatme, V. P. A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol., 13: 4556-4571, 1993.
37. Colombel, M., Symmans, F., Ge, S., O'Toole, K., Chopin, D., Benson, C., Olsson, C., Korsmeyer, S., and Buttgam, R. Detection of apoptosis-suppression oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am. J. Pathol., 143: 390-400, 1993.
38. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (Washington DC), 257: 674-678, 1992.
39. Kim, S. J., Park, K., Rudkin, B. B., Dey, B. R., Sporn, M. P., and Roberts, A. B. Nerve growth factor induces transcription of transforming growth factor-β1 through a specific promoter element in PC12 cells. J. Biol. Chem., 269: 3739-3744, 1994.
40. Colby, W. W., Chen, E. Y., Smith, D. H., and Levinson, A. D. Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (Lond.), 301: 722-725, 1983.
41. Nicolaides, N. C., Gualdi, R., Casadevall, C., Manzella, L., and Calla-bretta, B. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol., 11: 6166-6176, 1991.
42. Fleming, W. H., Hamel, A., MacDonald, R., Ramsey, E., Pettigrew, N. M., Johnston, B., Dogg, J. G., and Matusik, R. J. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res., 46: 1535-1538, 1986.
43. Truong, L. D., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T., and Thompson, T. C. Association of transforming growth factor-β1 with prostate cancer: an immunohistochemical study. Hum. Pathol., 24: 4-9, 1993.
44. Kimura, G., Kasuya, J., Giannini, S., Kawachi, M. H., and Fujita-Yamaguchi, Y. Inhibition of IGF-II-stimulated growth of prostate cancer cells by IGF-I receptor-specific monoclonal antibody and anti-sense oligonucleotide of IGF-II messenger RNA. J. Urol., 151: 367, 1994.
45. Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., and Rauscher, F. J. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science (Washington DC), 253: 1550-1556, 1991.
46. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. P., and Rauscher, F. J. Repression of transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol., 8: 595-602, 1994.
47. Ahmed, M. M., Venkatasubbarao, K., Fruitwala, S. M., Muthukkumar, S., Wood, D. P., Sells, S. F., Mohiuddin, M., and Rangnekar, V. M. EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells. J. Biol. Chem., 271: 29231-29237, 1996.
48. Svaren, J., Sevetson, B. R., Apel, E. D., Zimonjic, D. B., Popescu, N. C., and Milbrandt, J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol., 16: 3545-3553, 1996.
49. Russo, M. W., Sevetson, B. R., and Milbrandt, J. Identification of NAB1, a repressor of NGF1-A- and Krox-20-mediated transcription. Proc. Natl. Acad. Sci. USA, 92: 6873-6877, 1995.